Globe Life Inc. Common Stock (GL) fair value

ACCE thesis

Globe Life sells mostly small, low-face-amount whole life and term policies, primarily through its American Income and Liberty National brands, to middle-income households in the US, where the company's agent force and direct-to-consumer channels do the selling. The moat is distribution: a large, tenured agency network and a policy mix that holds up through the cycle, reflected in a 20.9% ROE and a 24.6% operating margin. Revenue growth of 8.0% is solid for a life insurer, and the stock is priced at 11.1x trailing and 10.2x forward earnings, a modest multiple for that profitability. The forward multiple sitting below the trailing one implies consensus expects earnings to keep rising, which is the core question for a deeper look: whether agency productivity and premium growth can sustain that trajectory. Because the company is outside major indices, the discount may partly reflect limited institutional ownership rather than fundamentals, which is worth checking against the operating data.